Targeting of IL-22 may have therapeutic potential for treatment of diseases in which the IL-22 signaling pathway is implicated including inflammatory bowel disease, inflammatory skin disorders or multiple sclerosis. The gene discussed is IL22; the disease is inflammatory bowel disease.